Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?

por Roviello, Giandomenico, Buti, Sebastiano, Cattrini, Carlo, Mennitto, Alessia, Messina, Carlo, Airoldi, Chiara, Vannini, Gianmarco, Bersanelli, Melissa
Publicado 2021

Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives

por Roviello, Giandomenico, Catalano, Martina, Santi, Raffaella, Palmieri, Valeria Emma, Vannini, Gianmarco, Galli, Ilaria Camilla, Buttitta, Eleonora, Villari, Donata, Rossi, Virginia, Nesi, Gabriella
Publicado 2021

Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing

por Lavacchi, Daniele, Fancelli, Sara, Buttitta, Eleonora, Vannini, Gianmarco, Guidolin, Alessia, Winchler, Costanza, Caliman, Enrico, Vannini, Agnese, Giommoni, Elisa, Brugia, Marco, Cianchi, Fabio, Pillozzi, Serena, Roviello, Giandomenico, Antonuzzo, Lorenzo
Publicado 2023